In around 90 percent of PsA cases, the joint symptoms only appear after the skin manifestations. Scientific studies have shown that a delayed PsA diagnosis can have unfavorable prognostic implications. Recently published consensus recommendations therefore suggest that patients with plaque psoriasis should be screened for joint involvement once or twice a year. Various screening methods can be combined.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Adrenogenital syndrome
Clinical care from birth to adulthood
- New approvals, current study data and ADC development
Antibody-drug conjugates in gynecologic oncology
- From symptom to diagnosis
Pneumology – Covid-19: a review
- Abdominal aortic aneurysms in primary care
Risk-stratified screening and prophylaxis
- Cardiology
Minimally invasive – the quiet triumph of modern heart surgery
- Plastic surgery and reconstructive microsurgery for DFS
Functional limb preservation between infection control, vascular medicine and resurfacing
- Age-related neurocognitive disorders